MedTrace Logo

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

NCT00476671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-07-17

No results posted yet for this study

Summary

To assess the prevalence and risk factors of neurocognitive impairment and psychiatric comorbidities in HIV infected patients who have undetectable viral load, have been on HAART for at least 1 year and have no history of CNS infection.

Conditions

  • HIV Infections

Interventions

PROCEDURE

lumbar puncture, MRI, MRS

lumbar puncture, MRI, MRS are only performed in patients with HIV associated dementia

Sponsors & Collaborators

  • University of Hawaii

    collaborator OTHER

  • SEARCH Research Foundation

    collaborator OTHER

  • Chulalongkorn University

    collaborator OTHER

  • University of Missouri, Department of Psychology, Division of Neuroscience

    collaborator OTHER

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Jintanat Ananworanich, MD, Ph.D · The HIV Netherlands Australia Thailand Research Collaboration

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-04-30
Completion
2008-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00476671 on ClinicalTrials.gov